Explore end-to-end solutions throughout development — from portfolio optimization and regulatory strategy, to Phase I-IV clinical trials, market access planning, and more.
See solutionsWHAT WE DO
HOW WE DO IT
Get the personal, responsive, and committed approach of a small CRO, with all the benefits of a large CRO, to help you develop life-changing treatments for patients.
Learn moreUtilize our expertise across therapeutic areas, combining innovative trial designs, leading clinical and regulatory expertise, global reach, and a passion for changing patient lives.
See expertiseTherapeutic Expertise
Cross-Therapeutic Expertise
Our experts help you stay at the forefront of the industry - and ahead of change.
See insightsNew Medicines, Novel Insights
Thinking about joining a clinical trial? Learn the drug development process, what it’s like to participate, how to find a trial, and answers to frequently asked questions.
Learn moreINTERESTED IN PARTICIPATING?
HEAR FROM REAL PATIENTS
TRIAL SITES
Want to collaborate with us to offer clinical trials at your site? We would welcome the opportunity to discuss.
Learn moreWe are one of the largest CROs in the world, speeding life-changing medicine to market by engaging patients With Heart™. Learn about who we are, what we do, and what we believe.
About ParexelWhat can we help you find today?
Whether you’re a team of two or a biotech company with more than 100, our dedicated team of Biotech experts will amplify your team's expertise to help you uncover insights faster to impact patient lives.
From regulatory and commercial strategy to cutting-edge trial design and execution, our team of experts anticipate and adaptively deliver the solutions you need, when you need them.
At Parexel Biotech, we combine our established end-to-end operational approach with biotech teams who have the expertise and experience to anticipate and adapt throughout development, mitigating risk at every step. Our talented experts have the knowledge and wisdom of having done it before, collaborating with your team, no matter how big or small, to help you see the unseen solutions and bring life-changing treatments to patients.
As a biotech company, you’re at the forefront of innovation — dedicated to bringing life-changing treatments to patients.
And at Parexel Biotech, we have the unique expertise to supercharge your clinical development.
We share your passion to change lives, and give you access to a deep, diverse team of world-class experts.
We offer a right-size solution — providing the personal, responsive, and committed approach of a small CRO, with all the benefits of a large CRO.
And as one of the first CROs to establish a dedicated operating model for biotechs, we’ve refined our approach to reflect the best practices we’ve learned working with small and mid-sized biotech clients as well as large pharmaceutical companies.
That’s what makes us a global CRO you can trust. You’re putting everything on the line, and our insights lead to the reliable timelines and operational excellence you need to get results.
At Parexel Biotech, performance is powered by people.
Our commercial strategists help prioritize portfolios, guide your investment opportunities, and deliver winning strategies for better outcomes.
The team includes many former regulators, HTA professionals, and industry experts, who see the unseen solutions — anticipating challenges before they arise and de-risking your development.
From Phase I first-in-human trials through to Phase IV, we use our vast experience to bring you and your patients closer to better outcomes.
And we partner with patients in trial design and delivery to help make clinical research a care option for anyone, anywhere.
From regulatory and commercial strategy to leading-edge trial design and execution, we provide the precise services you need through a configurable operating model — personalized to your project, no matter the size or scale.
That includes matching your unique requirements with an experienced, dedicated team who’ll advise, guide, and communicate with you at every step.
These experts’ passion, insights, and mastery fuel their ability to see the unseen obstacles and build smart solutions to simplify your development.
And their expertise is further amplified… by the scalable and agile global resources you’ll only find within a large CRO, that offers a unique operating model and customer experience for biotech.
When you partner with Parexel Biotech, we’ll work as one equally committed team to speed your innovation to the patients who need it most.
Because everything we do, we do with heart.
(Source KMR Benchmarking Report 2023)
(Source KMR Benchmarking Report 2023)
Advantages
Leveraging our dedicated biotech operations group, we match your unique requirements with an experienced team that anticipates and adaptively delivers the solutions you need. We'll work closely with you to amplify your capabilities, but we’re also accountable, taking it upon ourselves to solve problems and seize opportunities as soon as they arise.
We’re passionate about the patients you serve — and your trial’s success is dependent upon them. That’s why we strive to improve clinical trial diversity and partner with patients to help shape protocols, reduce trial burden, and increase retention. By gathering input from patients, caregivers, and investigative site staff worldwide, we’re able to develop the most efficient, empathetic path forward.
No matter where you’re conducting research, we have the global reach and expertise to help you navigate competitive, regulatory, and reimbursement landscapes in all major markets, including full capabilities in China. We deliver clinical development programs worldwide to rapidly find the patients waiting for your treatment.
We’ll help you start commercial planning early to set up a clear path to investment and revenue and avoid unnecessary delays. This includes weeding out unpromising product candidates to mitigate risk and focusing on products with the best chances of success. We’ll also help you clearly articulate a coherent product value story, from start to finish, so it’s easier to raise funds, make smarter development choices, gain market share, win reimbursement, and accelerate commercialization.
Explore our welcome experience to learn what sets us apart and discover why we are so passionate about biotech as you are.
Our experts in biotech
Jim Anthony
President and Global Head, Parexel Biotech
Vicky Hsu
Senior Vice President, Biotech Project Leadership, APAC
Mika Pollack
Project Director
Tasha Disney
Senior Vice President, Biotech Partnerships
Skip Sands
Senior Vice President of CCS, and Senior Medical Officer
Mwango Kashoki, M.D., M.P.H.
Senior Vice President, Global Head of Regulatory Strategy
Our experts in biotech
Jim Anthony
President and Global Head, Parexel Biotech
Vicky Hsu
Senior Vice President, Biotech Project Leadership, APAC
Mika Pollack
Project Director
Tasha Disney
Senior Vice President, Biotech Partnerships
Skip Sands
Senior Vice President of CCS, and Senior Medical Officer
Mwango Kashoki, M.D., M.P.H.
Senior Vice President, Global Head of Regulatory Strategy
Leading Insights
Podcast
Leveraging people, processes and technology to deliver for biotech
Oct 1, 2024
Podcast
De-risking Drug Development | Episode 5: Expand the use and value of your product over time
Sep 25, 2024
Podcast
De-risking Drug Development | Episode 4: Implement market launch strategy, pre-approval
Sep 25, 2024
Whitepaper
Biotech Innovation: Linking real-world data and patient insights to help demonstrate asset value
Aug 7, 2024
Podcast
De-risking Drug Development | Episode 3: Plan how to get to market quickly, post proof-of-concept
Jul 16, 2024
Podcast
Enabling Successful Sites, Ep3: Taking the complexity out of oncology clinical trials
Jun 28, 2024
Podcast
Enabling Successful Sites, Ep2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Podcast
De-risking Drug Development | Episode 2: Focus on safety and efficacy and prove quickly that your product works
Jun 19, 2024
Podcast
De-risking Drug Development | Episode 1: How to drive value in pre-clinical development
May 28, 2024
Playbook
Early-phase development strategies for navigating regulatory complexity in the EU
Apr 29, 2024
Blog
Scientific Advances: Catalyst for Biotech Investment and Innovation in Clinical Development
Mar 12, 2024
Article
Near-term strategies for biotech drug developers facing shifting healthcare dynamics
Feb 14, 2024
Playbook
What emerging trends in the FDA’s most coveted designations might tell us
Feb 8, 2024
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Webinar
Adaptive strategies for more efficient, data-rich and patient-friendly trials
May 28, 2023
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Article
8 things you need to know about eCTDs in China
Jul 1, 2022
Leading Insights
Podcast
Leveraging people, processes and technology to deliver for biotech
Oct 1, 2024
Podcast
De-risking Drug Development | Episode 5: Expand the use and value of your product over time
Sep 25, 2024
Podcast
De-risking Drug Development | Episode 4: Implement market launch strategy, pre-approval
Sep 25, 2024
Whitepaper
Biotech Innovation: Linking real-world data and patient insights to help demonstrate asset value
Aug 7, 2024
Podcast
De-risking Drug Development | Episode 3: Plan how to get to market quickly, post proof-of-concept
Jul 16, 2024
Podcast
Enabling Successful Sites, Ep3: Taking the complexity out of oncology clinical trials
Jun 28, 2024
Podcast
Enabling Successful Sites, Ep2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Podcast
De-risking Drug Development | Episode 2: Focus on safety and efficacy and prove quickly that your product works
Jun 19, 2024
Podcast
De-risking Drug Development | Episode 1: How to drive value in pre-clinical development
May 28, 2024
Playbook
Early-phase development strategies for navigating regulatory complexity in the EU
Apr 29, 2024
Blog
Scientific Advances: Catalyst for Biotech Investment and Innovation in Clinical Development
Mar 12, 2024
Article
Near-term strategies for biotech drug developers facing shifting healthcare dynamics
Feb 14, 2024
Playbook
What emerging trends in the FDA’s most coveted designations might tell us
Feb 8, 2024
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Webinar
Adaptive strategies for more efficient, data-rich and patient-friendly trials
May 28, 2023
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Article
8 things you need to know about eCTDs in China
Jul 1, 2022
Stay current with novel thinking and actionable insights from our experts.
